Introduction {#Sec1}
============

Accurate absolute quantification of radiotracer distribution is essential for dosimetry aimed at personalized radionuclide therapy and may improve prediction of therapy response, prevention of toxicity effects, and treatment follow-up \[[@CR1], [@CR2]\]. Both positron emission tomography (PET) and single-photon emission computed tomography (SPECT) hold the promise for absolute radioactivity quantification. However, for SPECT, quantification is considered less straightforward \[[@CR3], [@CR4]\] since its accuracy depends on a variety of factors, including the necessary use of a collimator, the varying detector trajectory, and the need for more complicated scatter correction and attenuation correction than in PET \[[@CR4]\]. Furthermore, quantification is influenced by both the reconstruction algorithm and settings. Recent developments in corrections for photon attenuation and scatter, collimator modeling and 3D reconstruction, e.g., by including resolution recovery and noise regulation, have improved reconstruction techniques, thereby enabling absolute SPECT quantification \[[@CR5]\]. The addition of an integrated computed tomography (CT) system not only provides an anatomical reference but enables accurate attenuation and scatter correction as well, improving quantification \[[@CR6]\]. Nowadays, combined SPECT/CT systems have become standard clinical practice.

Standardization of protocols in such a way that quantitative results can be reliably compared between systems requires more insight in their quantitative accuracy and performance. For PET/CT, differences in absolute quantification of various systems have been extensively characterized through the European Association of Nuclear Medicine initiative of EANM Research Ltd. (EARL). As part of this initiative, quantification of the most widely used PET radiotracer, ^18^F-fluorodeoxyglucose (^18^F-FDG), has been standardized in a multi-center setting through an accreditation program \[[@CR7], [@CR8]\].

Until date, no similar efforts for SPECT/CT have been carried out, which hampers multi-center research trials involving absolute SPECT quantification, especially those aimed towards dosimetry. The requirements on quantification for dosimetry are described in MIRD Pamphlet No. 23 \[[@CR9]\]. With the advent of, for example, ^177^Lu-PSMA therapy \[[@CR10]--[@CR13]\], it is expected that dosimetry will play a pivotal role for reliable determination of dose response relationships. But also our understanding of biomarker studies and already well-established radionuclide therapies in thyroid cancer \[[@CR14], [@CR15]\] or neuroendocrine tumors \[[@CR16]--[@CR20]\] may profit from optimized quantitative SPECT imaging for sophisticated dosimetry. In addition, quantitative measurements are increasingly used in diagnosis or disease monitoring \[[@CR21]\]. Several studies investigated the quantitative performance of SPECT for a variety of radionuclides, including technetium-99m (^99m^Tc) \[[@CR22], [@CR23]\], indium-111 (^111^In) \[[@CR24]--[@CR26]\], iodine-131 (^131^I) \[[@CR27]\], lutetium-177 (^177^Lu) \[[@CR28]\], yttrium-90 (^90^Y) \[[@CR29]\], or a combination of these \[[@CR30], [@CR31]\]. However, comparing these results of absolute quantification may be difficult as they were obtained on different SPECT/CT systems. Seret et al. \[[@CR32]\] compared four SPECT/CT systems for their quantitative capabilities and found that for objects which dimensions exceeded the SPECT spatial resolution several times, quantification was possible within a 10% error. For smaller structures, larger errors were observed necessitating partial volume effect correction. Furthermore, reconstruction artifacts degraded the accuracy of quantification. Hughes and colleagues compared image quality \[[@CR33]\] of three SPECT/CT systems for cardiac applications. They showed that these systems performed differently in terms of quantitative accuracy, contrast, signal-to-noise, and uniformity. In a different study \[[@CR34]\] in which they compared the same three SPECT/CT systems, they showed that image resolution is very much dependent on the reconstruction algorithm. In recent years, various SPECT/CT and software vendors have responded to the increasing need for SPECT quantification and now commercially offer software packages for quantification of several radionuclides including ^99m^Tc, ^111^In, ^131^I, and ^177^Lu \[[@CR35]--[@CR38]\].

The aim of this study is to compare absolute quantification for state-of-the-art SPECT/CT systems from different vendors at different imaging centers for ^99m^Tc. Multiple quantitative reconstruction algorithms that are currently commercially available are included in the comparison. The quantitative accuracy and inter-system variability of recovery coefficients (RC) are determined using various phantom experiments. The effects of lesion volume, patient size, reconstruction algorithm, and post-processing on RC are investigated. The results of these comparisons provide a first step towards a vendor-independent standard for absolute quantitative SPECT/CT that would allow transferability of the obtained metrics \[[@CR39]\].

Methods {#Sec2}
=======

SPECT/CT systems {#Sec3}
----------------

Data were acquired on five state-of-the-art SPECT/CT systems from three manufacturers: a Discovery NM/CT 670 Pro (GE Healthcare, Milwaukee, USA), a Precedence 6 (Philips Healthcare, Best, The Netherlands), a Symbia Intevo 6, and two Symbia T16's (Siemens Healthineers, Erlangen, Germany) (Table [1](#Tab1){ref-type="table"}). Table 1Characteristics of all used SPECT/CT systems with LEHR collimatorSystemDiscovery NM/CT 670 ProPrecedence 6Symbia Intevo 6Symbia T16Detector crystal3/8" NaI3/8" NaI3/8" NaI3/8" NaIPMT\*59555959FOV\*40 × 54 cm38.1 × 50.8 cm38.7 × 53.3 cm38.7 × 53.3 cmHole shapeHexagonalHexagonalHexagonalHexagonalNumber of holes (× 1000)Not specified86.4148148Collimator hole diameter1.50 mm1.40 mm1.11 mm1.11 mmHole length35 mm32.8 mm24.05 mm24.05 mmSeptal thickness0.2 mm0.152 mm0.16 mm0.16 mmSensitivity for ^99m^Tc @ 10 cm72 cps/MBq66 cps/MBq91 cps/MBq91 cps/MBqSeptal penetration @ 140 keV0.3%1.3%1.5%1.5%Planar resolution^†^7.4 mm7.4 mm7.5 mm7.5 mmSPECT central resolution^†^6.4 mm4.4 mm4.4 mm4.4 mmSPECT peripheral radial resolution^†^5.7 mm4.2 mm4.0 mm4.0 mmSPECT peripheral tangential resolution^†^5.1 mm4.3 mm3.9 mm3.9 mm\* (*C*)*FOV* (center) field of view, *PMT* photomultiplier tube† Spatial resolution without scatter (LEHR collimator at 10 cm, (full width at half maximum (FWHM) in CFOV \[mm\], 3/8" crystal)

Phantoms {#Sec4}
--------

A NEMA IEC body phantom without lung insert was used (Fig. [1](#Fig1){ref-type="fig"}). This phantom represents a patient with a body mass index (BMI) of 25 kg/m^2^ (which is considered normal) and contains six spheres with inner diameters (and corresponding volumes) of 10 mm (0.5 ml), 13 mm (1.2 ml), 17 mm (2.6 ml), 22 mm (5.6 ml), 28 mm (11.5 ml), and 37 mm (26.5 ml). To evaluate the effect of patient size on SPECT quantification, two additional custom-made phantoms were used on some systems that were similar to the shape of the NEMA IEC body phantom, but with larger diameters, reflecting a larger BMI of obese patients (Table [2](#Tab2){ref-type="table"}). The spheres from the NEMA IEC body phantom were also used for the increased body size phantoms. Fig. 1The phantoms used to determine the RC. Upper phantom: NEMA IEC body phantom. Lower two phantoms: custom-made phantoms reflecting a larger body mass index (BMI, kg/m^2^) of patients. Note that the lower two phantoms are depicted without spheres inset Table 2Phantom sizes and corresponding patient characteristicsPhantomVolume (l)Waist circumference (cm)Corresponding patient BMI\* (kg/m^2^)Small (NEMA phantom)9.708525Medium14.7310028Large25.9613047\* *BMI* body mass index

For all phantoms, the spheres and background compartment were filled with a homogeneous solution of ^99m^Tc-pertechnetate in water with a concentration of approximately 100 kBq/ml and 10 kBq/ml, respectively, resulting in a sphere-to-background ratio of 10:1 similar to EARL guidelines for ^18^F-FDG PET imaging \[[@CR8]\]. All ^99m^Tc-pertechnetate activities were measured in the clinical radionuclide dose calibrators present in the participating hospitals, which undergo regular quality control according to national guidelines \[[@CR40]\].

Data acquisition and reconstruction {#Sec5}
-----------------------------------

Harmonized acquisition protocols were used for all measurements. Images were acquired with a low-energy high-resolution (LEHR) collimator (Table [1](#Tab1){ref-type="table"}) in step and shoot mode, 128 projections (64 per detector head) (Discovery NM/CT 670 Pro: 120 projections, 60 per detector head), 20 s per projection, zoom factor 1.0, matrix size 128 × 128 (Symbia Intevo, 256 × 256), a photon energy window of 140 keV ± 15% and the detector trajectory set to body contour. Data from the standard NEMA phantom were acquired five times repetitively to assess system-specific repeatability. The time per angle was adjusted to obtain similar count statistics for each replicate.

Data were reconstructed with two reconstruction methods to assess its influence on quantification. First, vendor-specific 3D iterative reconstruction algorithms that included scatter correction, CT-based attenuation correction (for acquisition parameters see Additional file [1](#MOESM1){ref-type="media"}: Table S1) and resolution recovery with institute-specific settings used in clinical practice \[[@CR3]\] were used. This included two quantitative reconstruction algorithms that are currently commercially available (GE Q.Metrix and Siemens xSPECT Quant). Second, data were reconstructed with a vendor-neutral quantitative reconstruction algorithm (Hybrid Recon v1.1.2; Hermes Medical Solutions, Stockholm, Sweden) (Table [3](#Tab3){ref-type="table"}). Table 3Reconstruction and quantification parameters and processing software used in this studySystemDiscovery NM/CT 670 ProPrecedence 6Symbia Intevo 6Symbia T16 system 1Symbia T16 system 2AllImaging centerLeiden University Medical CenterMaastricht University Medical CenterNoord West ziekenhuis GroepRadboud University Medical CenterErasmus University Medical CenterAllReconstructionOSEM\* + Evolution with PSF\* correctionOSEM\* + Astonish with PSF\* correctionWeighted Conjugate Gradient + xSPECT with PSF\* correctionOSEM\* + Flash 3D with PSF\* correctionOSEM\* + Hybrid Recon V1.2 with PSF\* correctionOSEM\* + Hybrid Recon V1.2 with PSF\* correctionQuantificationQ.MetrixManual analysisxSPECT QuantManual analysisHermes SUV SPECTHermes SUV SPECTIterations9 \[[@CR5]\]324655Subsets10162161616Post-reconstruction filterNoneNone7.5 mm (Gaussian)8.4 mm (Gaussian)5 mm (Gaussian)5 mm (Gaussian)ProcessingGE Xeleris 4.0 workstationPhilips Extended Brilliance WorkspaceSiemens Syngo.viaSiemens Inveon Research WorkplaceHermes Hybrid ViewerIn-house developed Python algorithmAttenuation correctionCT-based, bilinear conversion of HU into attenuation coefficients at 140 keVCT-based, HU segmentation using a step-like law, bilinear conversion of HU into attenuation coefficients at 140 keVCT-based, bilinear conversion of HU into attenuation coefficients at 140 keVCT-based, bilinear conversion of HU into attenuation coefficients at 140 keVCT-based, Bilinear conversion of HU into attenuation coefficients at 140 keVCT-based, bilinear conversion of HU into attenuation coefficients at 140 keVScatter CorrectionDEW\* (120 keV ± 10%)Kernel basedDEW\* (119 keV ± 7.5%)DEW\* (119 keV ± 10%)Monte Carlo-basedMonte Carlo-basedImage voxel size2.21 × 2.21 × 2.21 mm^3†^4.7 × 4.7 × 4.7 mm^3^2.54 × 2.54 × 2.54 mm^3^4.8 × 4.8 × 4.8 mm^3^4.8 × 4.8 × 4.8 mm^3^4.8 × 4.8 × 4.8 mm^3^*\* OSEM* ordered subset expectation maximization, *PSF* point spread function, *DEW* dual energy window† Initial acquisition was performed with 128 × 128 matrix size and corresponding voxel size of 4.42 × 4.42 × 4.42 mm^3^. For quantification purposes this was interpolated to a 256 × 256 matrix size and corresponding voxel size of 2.21 × 2.21 × 2.21 mm^3^, as recommended by the vendor.

Calibration factor {#Sec6}
------------------

SPECT/CT systems were cross-calibrated for ^99m^Tc with the corresponding dose calibrators according to the manufacturer's recommendation or to the center's standard practice (Additional file [1](#MOESM1){ref-type="media"}: Table S2). Either one large or multiple smaller cylindrical regions of interest (ROIs) where drawn to obtain a calibration factor (CF) according to: $$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \mathrm{CF}\ \left[\frac{\mathrm{cps}/\mathrm{ml}}{\mathrm{kBq}/\mathrm{ml}}\right]=\frac{\left(\frac{\mu\ }{t\bullet n\bullet \nu}\right)}{A} $$\end{document}$$

where *μ* is the mean voxel value in the reconstructed image, *t* is the time per projection, *n* is the number of projections, *ν* is the voxel size, and *A* is the actual activity concentration in the phantom.

Analysis {#Sec7}
--------

To evaluate the absolute quantification of different SPECT/CT systems, RC for background and all six spheres were determined. RC was defined as the ratio of the measured activity concentration (*a*) and the true activity concentration (*A*) for each sphere: $$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \mathrm{RC}=\frac{a}{A} $$\end{document}$$

Volumes of interest (VOIs) for each sphere were determined with a region growing algorithm for which the cut-off threshold was calculated by \[[@CR41]\]: $$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ {\mathrm{VV}}_{\mathrm{thresh}}=0.5\bullet \left({\mathrm{VV}}_{\max, \mathrm{sphere}}+{\mathrm{VV}}_{\mathrm{mean},\mathrm{bg}}\right) $$\end{document}$$

where VV~thresh~ is the threshold voxel value, VV~max,sphere~ is the maximum voxel value in the sphere VOI, and VV~mean,bg~ is the mean voxel value in the background VOI. VV~mean,bg~ was determined by placing six cylindrical VOIs (diameter 4--5 cm) in a uniform region within the phantom.

The maximum and mean activity concentration for each sphere were determined, which resulted in both maximum and mean RC values, denoted as RC~max~ and RC~mean~, respectively.

The repeatability of the RC for each system was assessed with the reconstructed data of the five repetitive measurements by calculating the median absolute deviation (MAD) for each sphere diameter according to: $$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \mathrm{MAD}=\mathrm{median}\left(\left|{\mathrm{RC}}_i-\overset{\sim }{\mathrm{RC}}\right|\right) $$\end{document}$$

where RC~*i*~ is the recovery coefficient of measurement *i* and $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overset{\sim }{\mathrm{RC}} $$\end{document}$ is the median recovery coefficient of all repetitive measurements.

The MAD was also used to assess variability between systems for each sphere diameter. For each sphere, the median RC from each system was used in Eq. [4](#Equ4){ref-type=""}. This resulted in a sphere-specific MAD.

In addition to center-specific image analysis, all images were processed automatically in a standardized way using in-house developed software in Python which uses the SimpleITK toolkit region growing algorithm to determine sphere-specific VOIs using the same region growing algorithm as described above (Table [4](#Tab4){ref-type="table"}) \[[@CR42], [@CR43]\]. Table 4Calibration factors for center-specific and vendor-neutral reconstructions, calculated for 128 projections and 20 s/projectionSystemCenter-specific CF\* (cps/kBq)CF for Hermes SUV SPECT (kBq/cts)Discovery NM/CT 670 Pro0.0750.128Precedence 60.09860.143Symbia Intevo 61.00 \[-\]^†^0.112Symbia T16 system 10.09510.114Symbia T16 system 20.1100.110\* *CF* calibration factor† Data is already quantitative in kBq therefore no calibration factor is stated

Results {#Sec8}
=======

Calibration factor {#Sec9}
------------------

The calibration factors that were used to determine the RC for each system can be found in Table [4](#Tab4){ref-type="table"}.

Recovery coefficient {#Sec10}
--------------------

Differences (indicated as mean ± standard deviation) between the RC determined using standardized processing software versus center-specific processing software were 2 ± 3% for RC~mean~ and 0 ± 3% RC~max~. Since these differences were considered negligible, all data were processed using the standardized processing software (Python) as described earlier (performed centralized by two authors on all data).

The median recovery coefficient of the background compartment of the phantom was 1.01 (range, 0.93--1.07). The sphere-to-background activity concentration ratio was 10.6 ± 0.4:1 for all systems. Images obtained on all five systems showed different visual results (Fig. [2](#Fig2){ref-type="fig"}). Fig. 2Images of the NEMA IEC body phantom for all systems, reconstructed with a vendor-specific algorithm

For all systems, both RC~mean~ and RC~max~ decreased with decreasing sphere diameter (Fig. [3](#Fig3){ref-type="fig"}a--e). RC for the smallest sphere diameter (10 mm) could not be obtained because of the low contrast between the smallest sphere and the background for the used activity concentration ratio. Therefore, this sphere diameter is not considered in the remainder of this study. The variability in RC between systems is visualized in Fig. [3](#Fig3){ref-type="fig"}f. Fig. 3Recovery coefficient as a function of sphere diameter for all systems separately (**a**--**e**) and for all systems combined (**f**), for data reconstructed with a vendor-specific algorithm. Median and box plot for five repetitive measurements per system. (**a**) GE Discovery NM/CT 670 Pro, (**b**) Philips Precedence 6, (**c**) Siemens Symbia Intevo 6, (**d**) Siemens Symbia T16 system 1, (**e**) Siemens Symbia T16 system 2, (**f**) Median RC values for all systems combined

For each system, RC repeatability, expressed as the MAD, was best for the largest spheres, but good repeatability was shown for all sphere diameters (Table [5](#Tab5){ref-type="table"}). Table 5MAD per system (median and range over all sphere diameters) for data reconstructed using a vendor and center-specific algorithmRC~mean~RC~max~Discovery NM/CT 670 Pro0.02 (0.01---0.08)0.06 (0.02---0.10)Precendence 60.02 (0.00---0.04)0.03 (0.00---0.06)Symbia Intevo 60.01 (0.01---0.03)0.01 (0.00---0.05)Symbia T16 (1)0.02 (0.00---0.04)0.02 (0.01---0.05)Symbia T16 (2)0.07 (0.00---0.09)0.09 (0.03---0.19)

Effect of reconstruction algorithm on RC {#Sec11}
----------------------------------------

Vendor-neutral reconstruction showed a large decrease in inter-system variability (Figs. [4](#Fig4){ref-type="fig"} and [5](#Fig5){ref-type="fig"}). This finding is further confirmed by the MAD for reconstruction with vendor-specific versus vendor-neutral software (Table [6](#Tab6){ref-type="table"}), which shows a median MAD of 0.10 and 0.17 (16 and 17%) for the RC~mean~ and RC~max~ of vendor-specific reconstruction, and a decreased median MAD of 0.04 and 0.05 (4 and 5%) for the RC~mean~ and RC~max~ of vendor-neutral reconstruction, respectively. Fig. 4Images of the NEMA IEC body phantom for all systems, reconstructed with a vendor-neutral algorithm Fig. 5Recovery coefficient for all systems combined as a function of sphere diameter for vendor-specific reconstruction (**a**) and vendor-neutral reconstruction (**b**) Table 6MAD per sphere diameter for all systems combined, using either vendor-specific or vendor-neutral reconstruction algorithms.Sphere\
diameterRC~mean~RC~max~Vendor-specificVendor-neutralVendor-specificVendor-neutral37 mm0.010.050.030.0528 mm0.100.020.160.0422 mm0.200.040.280.0617 mm0.110.040.180.1113 mm0.090.040.130.04

Effect of patient size on RC {#Sec12}
----------------------------

Medium and large phantom data were only reconstructed using a vendor-neutral algorithm, since results for the small phantom showed the smallest variability between systems for these settings. It can be seen in Fig. [6](#Fig6){ref-type="fig"} that variability of RC between systems increased in larger phantom volumes. Furthermore, smaller sphere diameters showed lower quantitative accuracy (lower RC values) indicating that reliable quantification of small volumes (\< 10 ml) in larger (patient) volumes is more challenging. Fig. 6RC per sphere diameter for (**a**) small phantom (BMI, 25 kg/m^2^), (**b**) medium phantom (BMI, 28 kg/m^2^), (**c**) large phantom (BMI, 47 kg/m^2^), (**d**--**e**) RC~mean~ and RC~max~ for all three phantom volumes (median only). All data was reconstructed using a vendor-neutral algorithm

Discussion {#Sec13}
==========

This study is a considerable step towards standardization of absolute SPECT quantification by investigating the quantitative accuracy of different SPECT/CT systems. The quantitative accuracy of individual SPECT-CT systems was assessed earlier for the GE Discovery NM/CT 670 system \[[@CR5]\], the Siemens Symbia Intevo system \[[@CR44]\] and the Hermes SUV SPECT quantitative reconstruction algorithm \[[@CR36]\]. Although an earlier study by Seret et al. \[[@CR32]\] also compared the quantitative capabilities of four SPECT/CT cameras, our study included the current state-of-the-art quantitative SPECT/CT systems that enable absolute quantification that were not available at that time.

Many factors contribute to the uncertainty in quantification even if acquisition protocols are standardized, including VOI outlining methodology, operator variability and activity measurement (dose calibrator uncertainty, cross calibration between dose calibrator, and SPECT/CT system) \[[@CR45]\] and in our study also phantom preparation. The median RC in the background compartment was found to be 1.01, which indicated reliable acquisition, reconstruction and analysis. However, for some systems and measurements, the background RC was as low as 0.93 or as high as 1.07. This deviation might of course also influence the sphere RC values and thereby introduce an increase in variability between quantification on different systems. Furthermore, this study showed that the largest contribution for inter-system variation is due to vendor-specific reconstruction settings. Vendor-neutral reconstruction reduced this variation two to threefold (median MAD). It is therefore paramount to harmonize SPECT/CT image reconstructions in a multi-center/multi-vendor setting.

In a clinical setting, it is expected that the variability in quantification between SPECT/CT systems will increase, due to for example patient positioning and patient volume (BMI). To this end, we compared the recovery of the hot spheres in differently sized phantoms on several SPECT/CT systems. Only minor, not clinically relevant differences between the phantoms representing a BMI of 25 and 28 kg/m^2^ were found, while this change in BMI implies a rather significant increase in patient circumference. We therefore expect that for patients with a normal to slightly increased BMI, it is not necessary to take patient circumference into account for quantification. For a high BMI of 47 kg/m^2^ on the other hand, activity could not be recovered for the smaller sphere diameters. This might be explained by the increased attenuation, decreased signal-to-noise ratio, and decreased spatial resolution due to increased source-detector distance in these larger volumes. This means that in patients with a high BMI, quantifying smaller lesions will be more challenging. Using more iterations in the reconstruction of images of larger patients might improve convergence and thereby improve resolution and prevent artifacts, which was also shown for SPECT/CT myocardial perfusion studies by Celler et al. \[[@CR46]\]. The effect of increased attenuation could be canceled by an increase in scan time per projection or by increasing patient dose. The impact of scan time and dosage on image quality and image quantification is interesting to investigate further, but this was not within our scope.

The phantom used in this study did not contain lung, air, or bone components. Therefore the results mainly reflect quantification accuracy for soft tissue lesions. Experiments were performed using ^99m^Tc-pertechnetate. This radionuclide is the most widely used in SPECT imaging, and quantification of ^99m^Tc holds potential in for example myocardial perfusion imaging \[[@CR47]\], functional lung scanning \[[@CR48]\], selective internal radiation therapy (SIRT) of liver tumors \[[@CR49], [@CR50]\], quantification in bone lesions \[[@CR51], [@CR52]\], and therapy monitoring in locally advanced breast cancer \[[@CR5]\]. In addition, since the radiotracer is widely available, it served as a suitable radionuclide to compare absolute quantification performance of SPECT/CT systems.

In the current study, an activity concentration ratio of 1:10 was used between the background and spheres, based on the ratio used for the same phantom in the EARL accreditation program. With lower activity concentration ratios, lower RC values are expected due to partial volume effects.

For one system, matrix size changes were necessary between vendor-specific and vendor-independent reconstructions. With this change, it is uncertain whether the improved inter-scanner variability is due to the vendor-neutral reconstruction algorithm, or to the change in matrix size. It was, however, the aim of our study to assess whether vendor-neutral reconstruction would improve inter-scanner variability. Which underlying parameter caused this improvement was not the goal of our study.

Both vendor dependent as well as vendor-neutral reconstructions showed Gibbs artifacts for all systems, which is a known result of resolution modeling. These artifacts occur especially in phantom reconstructions, with high contrast changes between different structures. In our study, a large contrast change was present between the inside and outside of the spheres. Despite this large contrast change, and its accompanying Gibbs artifact, all systems showed RC~mean~ values approaching unity for larger sphere sizes. When sphere size decreases, the edge ring artifacts will come very close to each other and eventually merge, resulting in a too high activity in the center of the sphere.

In this study, only one vendor-neutral reconstruction algorithm was used. In theory, another reconstruction algorithm, although not commercially available at this moment, could potentially influence the resulting metrics. For the current study, however, our aim was to assess the influence of the reconstruction algorithm on RC measurements which could be assessed by using a vendor-neutral algorithm.

Knowledge gained from this study can be used to assess the absolute quantitative accuracy for other radionuclides as well. This can serve as input for a standardization program for absolute SPECT quantification which can be used to improve sophisticated clinical dosimetry in radionuclide therapy studies, especially in a multi-center setting.

Conclusion {#Sec14}
==========

This study shows that absolute SPECT quantification is feasible in a multi-center and multi-vendor setting. With center-specific reconstructions, variability between systems was 0.01--0.20 and 0.03--0.28 (MAD) for RC~mean~ and RC~max~, respectively. Standardized reconstruction decreases this variability to 0.02--0.05 and 0.04--0.11. Variation between centers is mainly caused by the use of different reconstruction algorithms and/or settings. Patient size showed to be relevant for quantification, as it was observed that high patient volume (BMI 47 kg/m^2^) resulted in an increased variability among systems and impeded quantification of small lesions (\< 10 ml). Close agreement between vendors and centers is key for reliable multi-center dosimetry and quantitative biomarker studies. This study serves as a first step towards a vendor-independent standard for absolute quantification in SPECT/CT.

Supplementary information
=========================

 {#Sec15}

**Additional file 1: Table S1.** Settings of low dose CT protocols used for attenuation correction. **Table S2.** Cross-calibration protocols for dose calibrators to SPECT/CT system according to vendor recommendations.

^111^In

:   Indium-111

^131^I

:   Iodine-131

^177^Lu

:   Lutetium-177

^90^Y

:   Yttrium-90

^99m^Tc

:   Technetium-99m

BMI

:   Body mass index

CF

:   Calibration factor

CT

:   Computed tomography

DEW

:   Dual energy window

EARL

:   EANM Research Ltd.

FDG

:   Fluorodeoxyglucose

LEHR

:   Low-energy high-resolution

MAD

:   Median absolute deviation

OSEM

:   Ordered subset expectation maximization

PET

:   Positron emission tomography

PSF

:   Point spread function

RC

:   Recovery coefficient

RC~max~

:   Max recovery coefficient

RC~mean~

:   Mean recovery coefficient

ROI

:   Region of interest

SIRT

:   Selective internal radiation therapy

SPECT

:   Single-photon emission computed tomography

TEW

:   Triple energy window

VOI

:   Volume of interest
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